Oxford Medical Simulation Secures £5 Million Growth Financing from Salica Investments to Accelerate Expansion of Immersive Clinical Training

LONDON, UNITED KINGDOM – March 10, 2026 – Oxford Medical Simulation (“OMS”), the leading provider of immersive clinical simulation for healthcare and academic institutions, today announced that it has secured £5 million in growth financing from Salica Investments, the UK-based investment firm backing high-growth companies across the UK and Europe.

The funding will enable OMS to further scale its presence in US health systems and academic institutions, invest in product innovation – including AI-driven scenarios, learning analytics and workflow tools – and scale the infrastructure needed to deliver safer, more effective clinical training.

OMS works with hospitals, health systems and universities across the US, UK and internationally to provide realistic, AI-driven simulations that let clinicians and students practice anytime, anywhere. By combining immersive, repeatable training with robust learning analytics, OMS helps institutions improve clinical readiness, drive consistency and support workforce development in the face of ongoing staffing pressures.

“This financing allows us to invest confidently in the next phase of OMS,” said Michael Wallace, CEO of Oxford Medical Simulation. “Our partners in US healthcare and academia are focused on outcomes – safer practice, better-prepared staff and more efficient delivery. This growth capital from Salica means we can move faster on exactly those priorities: expanding our breadth and depth of content, deepening our analytics capabilities, and supporting more institutions to transform their training for the new generation of learners.”

“Oxford Medical Simulation is exactly the type of business we look to support,” said Usman Ali, Partner at one of the funds at Salica. “The team has built a differentiated platform, proven at scale, and is working with leading health systems and universities to address a critical need: giving clinicians and students the chance to practise safely. We are delighted to back OMS as they scale their impact across healthcare and education.”

About OMS

OMS (Oxford Medical Simulation) was founded nearly 10 years ago by clinicians who saw firsthand the gaps between education and experience, training and performance, and onboarding and excellence. And they set out to close them. Today, we bring clinical expertise to immersive simulations that elevate learners, empower educators, and transform health outcomes. With unmatched support, dynamic technology, and AI at our core, we build partnerships that advance training, deliver measurable improvement, and take on healthcare’s new reality.

About Salica

Founded originally as an investment firm focusing on the most promising businesses, Salica has evolved into a unique set of private market funds investing in equity and debt across multiple sectors and stages, predominantly across the UK.

Salica fuses traditional values with a contemporary approach and balances exacting processes with the agility to capture commercial opportunity and compelling investment returns. Our continuous search for new opportunities has led us to create a balanced collection of funds and relationships.

More details can be found at: www.salicainvestments.com

For more information, please contact: press@oxfordmedicalsimulation.com